NK
Nitul Kumar Thapar
About Nitul Kumar Thapar
Data last updated:
Nitul Kumar Thapar is a Director at Kamlesh Medical Centre Private Limited (since 2023) and Director at Akross Consulting Associates Private Limited (since 2026). The companies operate in Non-Profit Organizations and Real Estate. The largest current company by reported revenue is Kamlesh Medical Centre Private Limited at ₹17,845 (FY 2022).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 11 Apr 2023 | 2019 | ₹17,845 (FY 2022) | Active | |
| Director | 10 Jan 2026 | 2025 | Active |
Board colleagues of Nitul Kumar Thapar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Jyoti Thapar | 08590533 | Kamlesh Medical Centre Private Limited | Director |
| Manoj Kohli | 10950126 | Akross Consulting Associates Private Limited | Director |
| Siddhant Kohli | 10950127 | Akross Consulting Associates Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nitul Kumar Thapar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nitul Kumar Thapar
Nitul Kumar Thapar currently holds 2 directorships: Kamlesh Medical Centre Private Limited (Director, since 11 Apr 2023, revenue ₹17,845 (FY 2022)); Akross Consulting Associates Private Limited (Director, since 10 Jan 2026).
Nitul Kumar Thapar was first appointed on 11 Apr 2023 as Director at Kamlesh Medical Centre Private Limited. The most recent appointment on record is 10 Jan 2026 at Akross Consulting Associates Private Limited.
The current boards of Nitul Kumar Thapar's companies include Jyoti Thapar (Kamlesh Medical Centre Private Limited), Manoj Kohli (Akross Consulting Associates Private Limited), Siddhant Kohli (Akross Consulting Associates Private Limited).